$Aerpio Pharmaceuticals Inc(ARPO)$ H.C. Wainwright analyst Robert Burns upgraded to a “Buy” rating, also assigned the company a $22 price target.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
22美元的目标价格-ARPO将持有合并后公司14.8%的股份，因此22美元中的14.8%将为3.30美元。非常合理